Wisconsin
CNS clinical trials in Wisconsin
46 CNS studies are recruiting participants at sites in 39 cities across Wisconsin as of November 16, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Every Wisconsin city with a recruiting study
By research area: Depression (14), Multiple Sclerosis (12), Migraine (8), Parkinson's Disease (7), ADHD (2), Epilepsy (2), Schizophrenia (1).
Milwaukee (23), Madison (18), Kenosha (4), Eau Claire (2), Greenfield (2), Neenah (2), Waukesha (2), Antigo (1), Appleton (1), Berlin (1), Burlington (1), Cudahy (1), Delafield (1), Germantown (1), Grafton (1), Green Bay (1), La Crosse (1), Marinette (1), Marshfield (1), Medford (1), Mequon (1), Mukwonago (1), New London (1), Oconomowoc (1), Oconto Falls (1), Oshkosh (1), Racine (1), Rhinelander (1), Shawano (1), Sheboygan (1), Stevens Point (1), Sturgeon Bay (1), Summit (1), Two Rivers (1), Waupaca (1), Wausau (1), Wauwatosa (1), West Allis (1), Wisconsin Rapids (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in Wisconsin
Basic details from each study's public record (the 12 most recently updated of 46). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Phase 2
- Ages 18 to 80
- All sexes
- Sponsor
- Reunion Neuroscience Inc
- Recruiting in
- Madison
- Registry record
- NCT07002034 · updated
A Prospective, Multi-center, Randomized Controlled Blinded Trial Demonstrating the Safety and Effectiveness of VNS Therapy® System as Adjunctive Therapy Versus a No Stimulation Control in Subjects With Treatment-Resistant Depression
- No phase
- Ages 18 and older
- All sexes
- Sponsor
- LivaNova
- Recruiting in
- Madison
- Registry record
- NCT03887715 · updated
E-Mindfulness Approaches for Living After Breast Cancer
- Phase 3
- Ages 18 to 50
- All sexes
- Sponsor
- NRG Oncology
- Recruiting in
- Antigo · Appleton · Berlin · and 31 more U.S. locations
- Registry record
- NCT06748222 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in Wisconsin on ClinicalTrials.gov.
Parkinson's disease: recently updated in Wisconsin
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Madison
- Registry record
- NCT06989112 · updated
A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Madison
- Registry record
- NCT06345729 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Madison
- Registry record
- NCT06966700 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in Wisconsin on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in Wisconsin
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Phase 3
- Ages 18 to 60
- All sexes
- Sponsor
- Zenas BioPharma (USA), LLC
- Recruiting in
- Milwaukee
- Registry record
- NCT07067463 · updated
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
- Observational
- Ages 18 and older
- All sexes
- Sponsor
- TG Therapeutics, Inc.
- Recruiting in
- Greenfield · Milwaukee · Neenah · and 1 more U.S. location
- Registry record
- NCT06433752 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in Wisconsin on ClinicalTrials.gov.
Epilepsy: recently updated in Wisconsin
Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Neurona Therapeutics
- Recruiting in
- Milwaukee
- Registry record
- NCT05135091 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in Wisconsin on ClinicalTrials.gov.
Migraine: recently updated in Wisconsin
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Recruiting in
- Marshfield · Milwaukee
- Registry record
- NCT06972056 · updated
A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Kenosha
- Registry record
- NCT07645924 · updated
A Long-Term Safety Study of Elismetrep (K-304) in the Acute Treatment of Migraine
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- TriGemX Bio, Inc.
- Recruiting in
- Kenosha
- Registry record
- NCT07674654 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in Wisconsin on ClinicalTrials.gov.
Ask about studies in Wisconsin
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.
CNS Clinical Research does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections